{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,9]],"date-time":"2026-06-09T14:06:58Z","timestamp":1781014018716,"version":"3.54.1"},"reference-count":23,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2021,11,18]],"date-time":"2021-11-18T00:00:00Z","timestamp":1637193600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Cardiovasc. Med."],"abstract":"<jats:p><jats:bold>Background:<\/jats:bold> \u201cAtrial fibrillation Better Care\u201d (ABC) pathway has been proposed to improve the management of patients suffered from atrial fibrillation (AF). This integrated or holistic management approach comprise of three aspects, including \u201cA\u201d Avoid stroke or Anticoagulation; \u201cB\u201d Better symptom control with rate or rhythm control strategies; \u201cC\u201d Cardiovascular risk factor and Concomitant diseases management. We aimed to confirm the beneficial evidence of ABC pathway compliance in a Chinese AF cohort.<\/jats:p><jats:p><jats:bold>Method and Results:<\/jats:bold> From the Chinese Atrial Fibrillation registry (CAFR) dataset, a total of 19,187 non-valvular AF patients were enrolled, of which 4.365 (22.8%) were ABC pathway compliant (ABC compliance group). During a median follow-up of 4.1 \u00b1 1.8 years, The incident rate of all-cause death in ABC compliance group and non-ABC compliance group is 2.7 and 1.1 per 100 person-year (<jats:italic>p<\/jats:italic> &amp;lt; 0.001), the incident rate of ischemic stroke is 1.3 and 0.8% per 100 person-year (<jats:italic>p<\/jats:italic> &amp;lt; 0.001), the incident rate of composite outcome, which consist of all-cause death, ischemic stroke and intracranial hemorrhage, is 3.8 and 1.9 per 100 person-year (<jats:italic>p<\/jats:italic> &amp;lt; 0.001). On Cox multivariable analysis, ABC pathway shows an independently association with reduction of all-cause death [hazard ratio (HR) = 0.82; 95% confidence interval (CI) = 0.70\u20130.95] and the composite outcome (HR 0.86, 95% CI 0.76\u20130.96). The increasingly components of ABC integrated care compliance is associated with lower risk of all-cause death and composite events.<\/jats:p><jats:p><jats:bold>Conclusion:<\/jats:bold> In a large cohort of Chinese AF patients, ABC pathway compliance shows an independently association with reduction of all-cause death and composite outcome of all-cause death, ischemic stroke and intracranial hemorrhage. Better compliance of ABC integrated care contributes to lower HR for adverse events.<\/jats:p>","DOI":"10.3389\/fcvm.2021.762245","type":"journal-article","created":{"date-parts":[[2021,11,18]],"date-time":"2021-11-18T07:10:10Z","timestamp":1637219410000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":12,"title":["Integrated Care of Atrial Fibrillation Using the ABC (Atrial fibrillation Better Care) Pathway Improves Clinical Outcomes in Chinese Population: An Analysis From the Chinese Atrial Fibrillation Registry"],"prefix":"10.3389","volume":"8","author":[{"given":"Yu-Feng","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chao","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liu","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Du","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cai-Hua","family":"Sang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"De-Yong","family":"Long","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ri-Bo","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian-Zeng","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregory Y. H.","family":"Lip","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chang-Sheng","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2021,11,18]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"i4482","DOI":"10.1136\/bmj.i4482","article-title":"Atrial fibrillation and risks of cardiovascular disease, renal disease, and death: Systematic review and meta-analysis","volume":"354","author":"Odutayo","year":"2016","journal-title":"BMJ."},{"key":"B2","doi-asserted-by":"publisher","first-page":"2508","DOI":"10.1016\/j.jacc.2016.09.944","article-title":"Causes of death in anticoagulated patients with atrial fibrillation","volume":"68","author":"Gomez-Outes","year":"2016","journal-title":"J Am Coll Cardiol."},{"key":"B3","doi-asserted-by":"publisher","first-page":"1278","DOI":"10.1016\/j.amjmed.2016.06.045","article-title":"Causes of death and influencing factors in patients with atrial fibrillation","volume":"129","author":"Fauchier","year":"2016","journal-title":"Am J Med."},{"key":"B4","doi-asserted-by":"publisher","first-page":"1873","DOI":"10.1016\/S0140-6736(17)31072-3","article-title":"The future of atrial fibrillation management: integrated care and stratified therapy","volume":"390","author":"Kirchhof","year":"2017","journal-title":"Lancet."},{"key":"B5","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1093\/europace\/eux318","article-title":"Integrating new approaches to atrial fibrillation management: the 6th afnet\/ehra consensus conference","volume":"20","author":"Kotecha","year":"2018","journal-title":"Europace."},{"key":"B6","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1038\/nrcardio.2017.153","article-title":"The abc pathway: an integrated approach to improve af management","volume":"14","author":"Lip","year":"2017","journal-title":"Nat Rev Cardiol."},{"key":"B7","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1093\/europace\/euaa274","article-title":"Relation of outcomes to abc (atrial fibrillation better care) pathway adherent care in european patients with atrial fibrillation: An analysis from the esc-ehra eorp atrial fibrillation general long-term (afgen lt) registry","volume":"23","author":"Proietti","year":"2021","journal-title":"Europace."},{"key":"B8","doi-asserted-by":"publisher","first-page":"1286","DOI":"10.3390\/jcm9051286","article-title":"Compliance of atrial fibrillation treatment with the atrial fibrillation better care (abc) pathway improves the clinical outcomes in the middle east population: a report from the gulf survey of atrial fibrillation events (safe) registry","volume":"9","author":"Gumprecht","year":"2020","journal-title":"J Clin Med."},{"key":"B9","doi-asserted-by":"publisher","first-page":"1695","DOI":"10.1055\/s-0039-1693516","article-title":"Improved population-based clinical outcomes of patients with atrial fibrillation by compliance with the simple abc (atrial fibrillation better care) pathway for integrated care management: a nationwide cohort study","volume":"119","author":"Yoon","year":"2019","journal-title":"Thromb Haemost."},{"key":"B10","doi-asserted-by":"publisher","first-page":"1359","DOI":"10.1016\/j.amjmed.2018.06.012","article-title":"Improved outcomes by integrated care of anticoagulated patients with atrial fibrillation using the simple abc (atrial fibrillation better care) pathway","volume":"131","author":"Proietti","year":"2018","journal-title":"Am J Med"},{"key":"B11","doi-asserted-by":"publisher","first-page":"1261","DOI":"10.1016\/j.mayocp.2018.10.022","article-title":"Integrated care management of patients with atrial fibrillation and risk of cardiovascular events: the abc (atrial fibrillation better care) pathway in the athero-af study cohort","volume":"94","author":"Pastori","year":"2019","journal-title":"Mayo Clin Proc."},{"key":"B12","doi-asserted-by":"publisher","first-page":"e014932","DOI":"10.1161\/JAHA.119.014932","article-title":"Comprehensive management with the abc (atrial fibrillation better care) pathway in clinically complex patients with atrial fibrillation: a post hoc ancillary analysis from the affirm trial","volume":"9","author":"Proietti","year":"2020","journal-title":"J Am Heart Assoc."},{"key":"B13","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1093\/eurheartj\/ehaa612","article-title":"2020 esc guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the european association for cardio-thoracic surgery (eacts)","volume":"42","author":"Hindricks","year":"2021","journal-title":"Eur Heart J."},{"key":"B14","doi-asserted-by":"publisher","first-page":"1523","DOI":"10.1016\/j.jacc.2020.01.052","article-title":"Mobile health technology to improve care for patients with atrial fibrillation","volume":"75","author":"Guo","year":"2020","journal-title":"J Am Coll Cardiol."},{"key":"B15","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1136\/heartjnl-2020-317915","article-title":"Atrial fibrillation prevalence, awareness and management in a nationwide survey of adults in china","volume":"107","author":"Du","year":"2021","journal-title":"Heart."},{"key":"B16","doi-asserted-by":"publisher","first-page":"2759","DOI":"10.1111\/jce.14231","article-title":"Prevalence of modifiable risk factors and relation to stroke and death in patients with atrial fibrillation: a report from the china atrial fibrillation registry study","volume":"30","author":"Jiang","year":"2019","journal-title":"J Cardiovasc Electrophysiol."},{"key":"B17","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1186\/s12872-016-0308-1","article-title":"Rationale and design of the chinese atrial fibrillation registry study","volume":"16","author":"Du","year":"2016","journal-title":"BMC Cardiovasc Disord."},{"key":"B18","doi-asserted-by":"publisher","first-page":"2692","DOI":"10.1093\/eurheartj\/ehs071","article-title":"Nurse-led care vs. usual care for patients with atrial fibrillation: results of a randomized trial of integrated chronic care vs. routine clinical care in ambulatory patients with atrial fibrillation","volume":"33","author":"Hendriks","year":"2012","journal-title":"Eur Heart J."},{"key":"B19","doi-asserted-by":"publisher","first-page":"1006","DOI":"10.1016\/j.ahj.2007.03.008","article-title":"Guideline-adherent antithrombotic treatment is associated with improved outcomes compared with undertreatment in high-risk patients with atrial fibrillation. The euro heart survey on atrial fibrillation","volume":"153","author":"Nieuwlaat","year":"2007","journal-title":"Am Heart J."},{"key":"B20","doi-asserted-by":"publisher","first-page":"1511","DOI":"10.1093\/europace\/euab092","article-title":"The atrial fibrillation better care pathway for managing atrial fibrillation: a review","volume":"23","author":"Stevens","year":"2021","journal-title":"Europace"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1055\/a-1515-9630","article-title":"Adherence to the 'atrial fibrillation better care' pathway in patients with atrial fibrillation: impact on clinical outcomes-a systematic review and meta-analysis of 285,000 patients","author":"Romiti","year":"2021","journal-title":"Thromb Haemost"},{"key":"B22","doi-asserted-by":"publisher","first-page":"e000067","DOI":"10.1161\/JAHA.112.000067","article-title":"Impact of global geographic region on time in therapeutic range on warfarin anticoagulant therapy: data from the rocket af clinical trial","volume":"2","author":"Singer","year":"2013","journal-title":"J Am Heart Assoc."},{"key":"B23","doi-asserted-by":"publisher","first-page":"2560","DOI":"10.1253\/circj.CJ-15-0574","article-title":"Effects of regional differences in asia on efficacy and safety of edoxaban compared with warfarin\u2013insights from the engage af-timi 48 trial","volume":"79","author":"Shimada","year":"2015","journal-title":"Circ J."}],"container-title":["Frontiers in Cardiovascular Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcvm.2021.762245\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,11,18]],"date-time":"2021-11-18T07:10:12Z","timestamp":1637219412000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcvm.2021.762245\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11,18]]},"references-count":23,"alternative-id":["10.3389\/fcvm.2021.762245"],"URL":"https:\/\/doi.org\/10.3389\/fcvm.2021.762245","relation":{},"ISSN":["2297-055X"],"issn-type":[{"value":"2297-055X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,11,18]]},"article-number":"762245"}}